Carmelo Bengala
About
Carmelo Bengala is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research.
According to data from OpenAlex, Carmelo Bengala has authored 19 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in Carmelo Bengala's work include Breast Cancer Treatment Studies (9 papers), Advanced Breast Cancer Therapies (5 papers) and Cancer Treatment and Pharmacology (5 papers). Carmelo Bengala is often cited by papers focused on Breast Cancer Treatment Studies (9 papers), Advanced Breast Cancer Therapies (5 papers) and Cancer Treatment and Pharmacology (5 papers). Carmelo Bengala collaborates with scholars based in Italy, Spain and United States. Carmelo Bengala's co-authors include Marco Bregni, Salvatore Siena, Alessandro M. Gianni, Axel Hinke, Mario Boccadoro, Rainer Kimmig, Helmut Ostermann, Volker Möbus, Jonathan A. Ledermann and Paolo Pedrazzoli and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.
In The Last Decade
Carmelo Bengala
19 papers receiving 310 citations
Peers
Carmelo Bengala
Alpaslan Özgün Türkiye
Amanda Goldrick Australia
Marie‐Pierre Castex France
Rahul Hejmadi United Kingdom
Luciano Wannesson Switzerland
H Hagberg Sweden
C Lynch United States
Toshinari Muramatsu Japan
Hytham Al‐Masri United States
C Ghandour France
Citations per year, relative to Carmelo Bengala Carmelo Bengala (= 1×)
peers
Alpaslan Özgün
Countries citing papers authored by Carmelo Bengala
Since
Specialization
Citations
This map shows the geographic impact of Carmelo Bengala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmelo Bengala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmelo Bengala more than expected).
Fields of papers citing papers by Carmelo Bengala
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Carmelo Bengala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmelo Bengala. The network helps show where Carmelo Bengala may publish in the future.
Co-authorship network of co-authors of Carmelo Bengala
This figure shows the co-authorship network connecting the top 25 collaborators of Carmelo Bengala. A scholar is included among the top collaborators of Carmelo Bengala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmelo Bengala. Carmelo Bengala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Ghilli, Matteo, Carlotta Becherini, Icro Meattini, et al.. (2024). Management of the axilla in breast cancer patients: critical review, regional modified Delphi consensus and implementation in the Tuscan breast network. La radiologia medica. 129(6). 945–954.
2.
Re, Marzia Del, et al.. (2024). Pharmacological insights on novel oral selective estrogen receptor degraders in breast cancer. European Journal of Pharmacology. 969. 176424–176424.
3.
Munzone, Elisabetta, Meredith M. Regan, Saverio Cinieri, et al.. (2022). 216MO A randomized phase II trial of metronomic oral vinorelbine plus cyclophosphamide and capecitabine (VEX) vs weekly paclitaxel (P) as first- or second-line treatment in patients (pts) with ER+/HER2- metastatic breast cancer (MBC): The METEORA-II trial (IBCSG 54-16). Annals of Oncology. 33. S636–S637.
4.
Francini, Edoardo, Francesca Montagnani, Pier Vitale Nuzzo, et al.. (2020). Clinical outcomes of abiraterone acetate + prednisone (AA) + bone resorption inhibitors (BRI) versus AA alone as first-line therapy for castration-resistant prostate cancer (CRPC) with bone metastases (BM) in an international multicenter database.. Journal of Clinical Oncology. 38(6_suppl). 30–30.
5.
Zambetti, Milvia, Filippo Montemurro, Paolo Morandi, et al.. (2018). Safety profile of subcutaneous trastuzumab for the treatment of patients with HER2-positive early or locally advanced breast cancer: primary analysis of the SCHEARLY study. European Journal of Cancer. 105. 61–70.
6.
Masini, Cristina, Cinzia Iotti, Patrizia Ciammella, et al.. (2018). NIVES study: A phase II trial of nivolumab (NIVO) plus stereotactic body radiotherapy (SBRT) in II and III line of patients (pts) with metastatic renal cell carcinoma (mRCC).. Journal of Clinical Oncology. 36(15_suppl). TPS4602–TPS4602.
7.
Meattini, Icro, Giuseppe Curigliano, Carlotta Becherini, et al.. (2017). SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab. Medical Oncology. 34(5). 75–75.
8.
Russo, Giuseppe Lo, Lucio Crinò, Domenico Galetta, et al.. (2017). MA14.06 Nivolumab in Never Smoker Patients with Advanced Squamous NSCLC: Results from the Italian Expanded Access Programme (EAP). Journal of Thoracic Oncology. 12(1). S424–S425.
9.
Martino, Massimo, Francesco Lanza, Lorenzo Pavesi, et al.. (2015). High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment in High-Risk Breast Cancer: Data from the European Group for Blood and Marrow Transplantation Registry. Biology of Blood and Marrow Transplantation. 22(3). 475–481.
10.
Pedrazzoli, Paolo, Giovanni Martinelli, Alessandro M. Gianni, et al.. (2014). Adjuvant High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Support for High-Risk Primary Breast Cancer: Results from the Italian National Registry. Biology of Blood and Marrow Transplantation. 20(4). 501–506.
11.
Martino, Massimo, Alberto Ballestrero, Alberto Zambelli, et al.. (2012). Long-term survival in patients with metastatic breast cancer receiving intensified chemotherapy and stem cell rescue: data from the Italian registry. Bone Marrow Transplantation. 48(3). 414–418.
12.
Bengala, Carmelo. (2009). Recent advances in managing triple-negative breast cancers. F1000 Medicine Reports. 1.
13.
Nicola, Massimo Di, Andrea Necchi, Nicola Nicolai, et al.. (2009). 7100 High-dose sequential chemotherapy versus conventional-dose chemotherapy as first-line treatment for advanced poor prognosis germ-cell tumors: a multicenter Phase III Italian trial. European Journal of Cancer Supplements. 7(2). 422–422.
14.
Pedrazzoli, Paolo, A. M. Gianni, Alberto Ballestrero, et al.. (2008). Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell transplantation for breast cancer with > 9 positive nodes: 15-year results from the Italian registry. Journal of Clinical Oncology. 26(15_suppl). 592–592.
15.
Möbus, Volker, Hannes Wandt, Norbert Frickhofen, et al.. (2007). Phase III Trial of High-Dose Sequential Chemotherapy With Peripheral Blood Stem Cell Support Compared With Standard Dose Chemotherapy for First-Line Treatment of Advanced Ovarian Cancer: Intergroup Trial of the AGO-Ovar/AIO and EBMT. Journal of Clinical Oncology. 25(27). 4187–4193.
16.
Barkholt, Lisbeth, Marco Bregni, Mats Remberger, et al.. (2006). Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe. Annals of Oncology. 17(7). 1134–1140.
17.
Bengala, Carmelo, Claudio Zamagni, Paolo Pedrazzoli, et al.. (2006). Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study. British Journal of Cancer. 94(7). 1016–1020.
18.
Coombes, R. Charles, Anthony Howell, Marie A. Emson, et al.. (2005). High dose chemotherapy and autologous stem cell transplantation as adjuvant therapy for primary breast cancer patients with four or more lymph nodes involved: long-term results of an international randomised trial. Annals of Oncology. 16(5). 726–734.
19.
Gianni, Alessandro M., Corrado Tarella, Salvatore Siena, et al.. (1990). Durable and complete hematopoietic reconstitution after autografting of rhGM-CSF exposed peripheral blood progenitor cells.. PubMed. 6(2). 143–5.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Alpaslan Özgün Breakdown of academic impact, for papers by Amanda Goldrick Breakdown of academic impact, for papers by Marie‐Pierre Castex Breakdown of academic impact, for papers by Rahul Hejmadi Breakdown of academic impact, for papers by Luciano Wannesson Breakdown of academic impact, for papers by H Hagberg Breakdown of academic impact, for papers by C Lynch Breakdown of academic impact, for papers by Toshinari Muramatsu Breakdown of academic impact, for papers by Hytham Al‐Masri Breakdown of academic impact, for papers by C Ghandour